Media

Rekha Basu in her March 22 column opposes Iowa’s medical conscience bill permitting doctors to refuse to provide non-emergency medical treatments which violate their conscience due to religious or moral beliefs. She cites “abortion or gender-affirming surgery” as procedures that doctors must do or face discipline

To be a reliable tool, systematic reviews must provide unbiased recommendations about the efficacy of medical treatments based on a rigorous survey of potential harms, according to Dr. William Malone, the group’s co-founder. “When those standards aren’t met, the result isn’t clarity — it’s confusion dressed up as certainty."

The Department of Health and Human Services recently proposed a slate of regulations that would effectively ban hospitals from using puberty blockers for children, citing research that shows the drugs can cause irreversible harm. Activist groups decried the move, claiming that puberty blockers—when prescribed to children diagnosed with gender dysphoria—are reversible and merely pause development.

The Department of Health and Human Services just released its report on gender dysphoria. Its findings are impossible to ignore.

Drawing on systematic reviews in Europe and the U.S., the report shows that the evidence for medical interventions in minors is shakier than assumed -- and that the risks, including infertility, reduced bone density, cognitive effects, cardiometabolic disease, psychiatric complications, and surgical harms, are more serious than the public has been led to believe.

Recent lawsuits and a shift by a major medical organization are putting pediatric gender-transition treatments in the United States under new scrutiny, as critics point to weak evidence, mounting legal challenges from detransitioners, and growing professional divisions that could reshape the field.

An article in the Bulletin of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP) summarizes the proceedings of the SEGM Conference 2025.

Endocrinologist and SEGM co-founder Dr. Will Malone argues that pediatric medical transition lacks solid evidence of long-term safety or benefit, while activist pressure and institutional censorship in the U.S. have suppressed scientific scrutiny and debate.

Endocrinologist and SEGM co-founder Dr. Will Malone contends that pediatric gender medicine in the U.S. has abandoned scientific rigor, with weak evidence for medical interventions, growing international caution, and widespread activist-driven intimidation and censorship suppressing research, education, and open debate.

Today, the U.S. Department of Health and Human Services released the final, peer-reviewed version of its report, Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices. This publication updates the initial HHS Review, which was released on May 1, 2025.

Today, the Society for Evidence-Based Gender Medicine (SEGM) announced the launch of a new Continuing Medical Education (CME) series designed to equip clinicians with the latest evidence, perspectives, and best practices in the care of gender-dysphoric youth.